Mavenclad may help manage coexisting autoimmune diseases alongside MS, potentially reducing the need for extra drugs.
Certain gut bacteria may influence the odds of developing MS, in part by altering the activity of specific immune cells, ...
Nanocurcumin was linked to better disability scores in small RRMS trials, but researchers say larger studies are needed.
MMR and chickenpox vaccines don't raise relapse risk for people with MS, a study found, supporting current vaccination ...
An experimental MS therapy given as a nasal spray has started dosing its final participant in a Phase 2a trial of people with ...
Supplementation with high-dose vitamin D for more than one year significantly reduced relapse risk and eased disability in ...
High-intensity physical exercise combined with melatonin supplements may offer more benefit to people with MS than either ...
A gene variant tied to more severe MS disability may also correlate with poor cognitive performance in healthy adults, per a ...
Changes in the upper spinal cord, measured on routine brain MRI, may help flag higher MS progression risk in people with RRMS ...
Aspirin and acetaminophen may help ease MS fatigue, improve temperature regulation, and increase exercise capacity, a study ...
Increasing the Ocrevus dose used in treating MS provided no additional benefit versus the approved regimen in trials with over 1,500 patients.
A lab study suggests cyclodextrins may help support myelin sheath repair in MS by reducing harmful fat buildup in immune cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results